Indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO) are overexpressed in various cancers and catalyze tryptophan degradation to KYN, which is further converted to KYNA by KYN aminotransferases (133). The gene discussed is TDO2; the disease is cancer.